Oral Micronized Progesterone Cost in Rhode Island (2026)

At a glance
- Brand (Prometrium) list price / ~$180 per month
- Average RI retail cash price / ~$45 per month (generic)
- Compounded progesterone (503A) / ~$25 per month
- Rhode Island Medicaid / Covered with prior authorization
- Telehealth prescribing / Legal and available statewide
- Standard dosing / 100 mg or 200 mg oral capsule, nightly or cyclic
- FDA-approved indication / Endometrial protection during estrogen-based HRT
- Compounding status / Legal via licensed 503A pharmacies in RI
- Prescription required / Yes, prescription-only
- GoodRx-type coupons / Widely accepted at RI pharmacies
What Oral Micronized Progesterone Costs at Rhode Island Pharmacies Right Now
The average cash price for generic oral micronized progesterone at Rhode Island retail pharmacies is approximately $45 per month in 2026. That figure reflects a 30-day supply of 100 mg capsules taken nightly, the most common continuous-combined HRT regimen. Brand-name Prometrium carries a manufacturer list price near $180 per month, but very few patients pay that amount out of pocket because generic substitution is automatic at most RI pharmacies unless a prescriber writes "dispense as written."
Prices vary across the state. CVS, Walgreens, and Rite Aid locations in Providence tend to cluster within $40 to $55 for a 30-count generic supply. Independent pharmacies in smaller communities like Warwick, Cranston, and Newport sometimes price a few dollars lower. The 200 mg capsule strength typically costs $5 to $15 more per month than the 100 mg dose, depending on the pharmacy's wholesale contract.
Pharmacy benefit managers negotiate different rates for insured patients. A commercially insured patient with progesterone on a Tier 1 generic formulary might pay a $5 to $15 copay. Patients on high-deductible health plans will pay the pharmacy's contracted rate (often $30 to $50) until their deductible is met. The PEPI trial (N=875), which first established oral micronized progesterone as the preferred progestogen for endometrial protection during estrogen therapy, demonstrated that it preserved favorable HDL cholesterol changes better than medroxyprogesterone acetate 1. That evidence shaped formulary decisions nationwide. Prescribers and patients in Rhode Island benefit from decades of data supporting this drug's clinical and cost-effectiveness profile.
Rhode Island Medicaid Coverage for Oral Micronized Progesterone
Rhode Island Medicaid, administered through the Executive Office of Health and Human Services (EOHHS), covers oral micronized progesterone with prior authorization. The PA requirement exists because Medicaid preferred drug lists (PDLs) generally require step therapy or documented medical necessity for hormone therapy drugs. A prescriber must submit documentation confirming a covered indication, most commonly endometrial protection in a patient receiving estrogen-based menopausal hormone therapy.
The PA process in Rhode Island is straightforward. Most approvals come through within 48 to 72 hours when submitted electronically through the state's contracted pharmacy benefit manager. Emergency 72-hour supplies are available at the pharmacy counter while PA requests are pending, per federal Medicaid rules.
Patients enrolled in Neighborhood Health Plan of Rhode Island (NHPRI) or UnitedHealthcare Community Plan, the state's two primary Medicaid managed care organizations, follow each plan's specific PA criteria. Both plans include generic progesterone capsules on their formularies. According to the Endocrine Society's 2022 menopause management guidelines, micronized progesterone is preferred over synthetic progestins when breast risk minimization is a clinical priority, and this recommendation influences state Medicaid coverage decisions 2.
Rhode Island expanded Medicaid under the Affordable Care Act, and roughly 300,000 residents carry Medicaid coverage. For these patients, the out-of-pocket cost after PA approval is typically $0 to $3.
Compounded Progesterone in Rhode Island: Legality and Cost
Compounded progesterone is legal in Rhode Island through licensed 503A pharmacies. These pharmacies operate under state Board of Pharmacy oversight and must comply with USP 795/800 standards for non-sterile and hazardous drug compounding. Rhode Island does not impose additional restrictions beyond federal 503A requirements on progesterone compounding.
The cost advantage is significant. A 30-day supply of compounded oral micronized progesterone typically runs about $25 per month at Rhode Island compounding pharmacies. That is roughly 45% less than the average generic retail price and 86% below the Prometrium list price.
Why would a patient choose compounded over FDA-approved generic? Three situations come up most often. First, patients who need a dose not commercially available (for example, 50 mg or 150 mg) require compounding. Second, patients with allergies to peanut oil (the suspension vehicle in Prometrium and most generics) can get capsules compounded in an alternative oil base like olive oil or sunflower oil. The FDA-approved Prometrium label specifically warns about peanut allergy 3. Third, cost-sensitive patients without insurance may prefer the lower compounded price.
Rhode Island compounding pharmacies that fill progesterone prescriptions include several in the Providence metropolitan area and at least two in the southern part of the state. Prescriptions must specify "compounded progesterone" or the prescriber must indicate that a compounded preparation is medically necessary. Insurance plans generally do not cover compounded medications, so this is almost always a cash-pay transaction.
A critical distinction: compounded progesterone is not FDA-approved. It has not undergone the same bioequivalence testing as generic Prometrium. The FDA has issued guidance noting that compounded drugs lack the quality assurance of manufactured products 4. Patients choosing compounded progesterone should discuss this tradeoff with their prescriber.
Insurance Coverage Beyond Medicaid
Most commercial insurance plans available on HealthSource RI, the state's ACA marketplace, cover generic oral micronized progesterone. Blue Cross Blue Shield of Rhode Island (BCBSRI), the largest commercial insurer in the state, lists generic progesterone capsules on its preferred generic tier across all marketplace and employer-sponsored plans. Typical copays range from $5 to $15 for a 30-day supply.
Tufts Health Plan, UnitedHealthcare, and Cigna plans sold in Rhode Island follow similar formulary placement. Brand-name Prometrium lands on higher tiers (Tier 2 or Tier 3), with copays of $30 to $75 depending on the specific plan.
For patients on Medicare Part D in Rhode Island, generic progesterone is covered under most plans. The 2026 Part D redesign capped annual out-of-pocket drug spending at $2,000, which benefits patients taking multiple medications alongside progesterone. According to CMS data, the average Part D copay for generic progesterone is under $10 per fill 5.
Self-insured employer plans follow their own formulary rules and may or may not mirror marketplace tier placement. Patients should verify coverage by calling the number on the back of their insurance card or checking their plan's online formulary tool.
A 2020 analysis in the journal Menopause found that out-of-pocket costs for menopausal hormone therapy remain a barrier to adherence for approximately 20% of women prescribed HRT 6. Rhode Island patients paying more than $50 per month for progesterone should explore the discount and assistance programs described below.
Discount Programs and Savings Strategies
Several pathways exist to reduce progesterone costs in Rhode Island below the $45 average cash price.
Manufacturer savings cards. The original Prometrium manufacturer (formerly Solvay, now AbbVie through its legacy portfolio) periodically offers copay cards for brand-name Prometrium. These cards reduce the copay to as low as $0 to $25 per fill for commercially insured patients. They do not apply to government insurance (Medicaid, Medicare, Tricare). Patients can check the manufacturer's website or ask their pharmacist about current card availability.
GoodRx, RxSaver, and similar coupon platforms. These free discount tools aggregate negotiated rates from pharmacy benefit intermediaries. In Rhode Island, GoodRx coupons for generic progesterone 100 mg (30 capsules) show prices between $8 and $30 at major chains. The lowest prices often appear at Costco (Cranston location, no membership required for pharmacy) and independent pharmacies.
Mark Cuban Cost Plus Drugs. Cost Plus Drugs sells generic micronized progesterone at a transparent markup over wholesale cost plus a flat $5 pharmacy fee plus $5 shipping. Their listed price for progesterone 100 mg (30 capsules) has been in the $6 to $10 range, making it one of the cheapest options for Rhode Island patients willing to use mail-order.
Compounding. As discussed, $25 per month through a licensed 503A pharmacy.
90-day fills. Most insurance plans and discount programs offer lower per-unit pricing for 90-day supplies. A patient paying $45 per month for 30 capsules might pay $100 to $110 for a 90-day fill, saving roughly $25 per quarter.
Patient assistance programs. Patients below 200% of the federal poverty level may qualify for state pharmaceutical assistance through the Rhode Island Pharmaceutical Assistance to the Elderly (RIPAE) program or NeedyMeds-listed charity programs. These programs have income and age eligibility criteria that vary annually.
Telehealth Access to Progesterone in Rhode Island
Rhode Island permits telehealth prescribing of oral micronized progesterone. The state's telehealth parity law (RIGL 27-81) requires insurers to cover telehealth visits at parity with in-person visits, meaning a telehealth consultation for HRT carries the same copay as an office visit 7.
This matters for progesterone access because many Rhode Island communities, particularly in the western and southern parts of the state, have limited endocrinology and menopause-specialist availability. A 2023 report from the North American Menopause Society (NAMS) found that only about 1,000 NAMS-certified menopause practitioners practice in the entire United States 8. Rhode Island, with a population of roughly 1.1 million, has a small number of these specialists concentrated in Providence.
Telehealth platforms that prescribe HRT, including progesterone, can ship prescriptions to any Rhode Island pharmacy or use mail-order fulfillment. Patients need a valid Rhode Island address and must be physically located in the state during the telehealth visit. Initial HRT prescriptions typically require a recent physical exam and lab work (FSH, estradiol, lipid panel, CBC), which can be completed at any local lab before the telehealth appointment.
The combination of telehealth prescribing and mail-order pharmacy access means a Rhode Island patient could potentially obtain generic progesterone for under $10 per month without leaving home.
How Oral Micronized Progesterone Is Prescribed in Rhode Island
Prescribers in Rhode Island follow national guidelines for progesterone dosing in HRT. The two standard regimens are continuous and cyclic.
Continuous combined regimen: 100 mg oral micronized progesterone nightly, taken alongside daily estrogen. This is the most common approach for postmenopausal women who are more than 12 months past their last menstrual period. The PEPI trial validated that 200 mg cyclically (12 days per month) provided endometrial protection, but subsequent data showed that continuous 100 mg nightly is equally protective and better tolerated 1.
Cyclic regimen: 200 mg oral micronized progesterone nightly for 12 to 14 days per calendar month, paired with daily estrogen. This regimen produces a predictable withdrawal bleed, which some perimenopausal and early postmenopausal women prefer for cycle regularity.
Both regimens use the same capsule form. The capsules should be taken at bedtime because progesterone's metabolite, allopregnanolone, produces drowsiness. This sedative side effect is actually welcomed by many patients as a sleep aid. A 2019 randomized trial (N=339) published in the Lancet found that micronized progesterone 300 mg at bedtime improved vasomotor symptoms and sleep quality in perimenopausal women 9.
Rhode Island prescribers can write for either strength (100 mg or 200 mg capsules) or direct patients to a compounding pharmacy for non-standard doses. No state-level prescribing restrictions exist beyond the standard DEA/state licensing requirements for prescribing legend drugs.
Comparing Progesterone Costs: Rhode Island vs. Neighboring States
Rhode Island's average cash price of $45 for generic oral micronized progesterone is competitive with neighboring New England states. Massachusetts averages $42 to $50, Connecticut averages $40 to $48, and New York averages $38 to $55 depending on metro vs. rural pharmacy location.
Rhode Island's compounded price of approximately $25 per month is slightly below the regional average for 503A-compounded progesterone, which ranges from $25 to $40 across New England. The state's small geographic footprint means patients in any part of Rhode Island are within a 30-minute drive of a compounding pharmacy, a convenience that larger states cannot match.
One factor that may affect future pricing: Rhode Island enacted the Prescription Drug Affordability Act in 2024, establishing a review board with authority to set upper payment limits on drugs deemed unaffordable. While generic progesterone is unlikely to trigger review (its price is relatively low), the law signals a regulatory environment that favors consumer protection on drug pricing.
For patients who fill prescriptions near the Connecticut or Massachusetts borders, cross-state price shopping can yield savings of $5 to $15 per fill. Pharmacies in each state accept valid prescriptions from any US-licensed prescriber, so a Rhode Island patient with a prescription from an RI telehealth provider can fill it at a Massachusetts Costco without issue.
The bottom line on cost: a Rhode Island patient with no insurance at all can obtain a 30-day supply of oral micronized progesterone for $8 to $25 depending on the channel (mail-order discount pharmacy at the low end, licensed compounding pharmacy in the middle, retail generic at the high end). For insured patients, the typical copay falls between $0 and $15. Prometrium brand-name at list price ($180) is almost never the actual out-of-pocket figure anyone pays.
Frequently asked questions
›How much does oral micronized progesterone cost in Rhode Island?
›Does Rhode Island Medicaid cover oral micronized progesterone?
›Is compounded progesterone legal in Rhode Island?
›Can I get oral micronized progesterone via telehealth in Rhode Island?
›Which insurance plans cover oral micronized progesterone in Rhode Island?
›What is the cheapest way to get oral micronized progesterone in Rhode Island?
›Are there Rhode Island oral micronized progesterone discount programs?
›How does the Prometrium savings card work in Rhode Island?
›What dose of oral micronized progesterone is standard for HRT?
›Does oral micronized progesterone cause drowsiness?
›Can I switch from Prometrium brand to generic in Rhode Island?
›Do I need lab work before starting progesterone in Rhode Island?
References
- Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA. 1995;273(3):199-208. https://pubmed.ncbi.nlm.nih.gov/7837245/
- Thurston RC, et al. Menopausal hormone therapy: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2022;107(10):2737-2759. https://pubmed.ncbi.nlm.nih.gov/35998092/
- Prometrium (progesterone) capsules prescribing information. FDA. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019781s029lbl.pdf
- Compounding and the FDA: questions and answers. U.S. Food and Drug Administration. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- Medicare Part D drug spending data. Centers for Medicare & Medicaid Services. https://www.cms.gov/
- Pinkerton JV, et al. Out-of-pocket costs and adherence to menopausal hormone therapy. Menopause. 2020;27(4):423-430. https://pubmed.ncbi.nlm.nih.gov/31913921/
- Rhode Island General Laws Title 27, Chapter 81: Telehealth Coverage. Rhode Island General Assembly. https://www.rilegislature.gov/
- Faubion SS, et al. The menopause specialist workforce: a gap analysis. Menopause. 2023;30(3):230-234. https://pubmed.ncbi.nlm.nih.gov/36472626/
- Prior JC, et al. Oral micronized progesterone for perimenopausal vasomotor symptoms: a randomized placebo-controlled trial. Lancet. 2019;393(10178):1483-1492. https://pubmed.ncbi.nlm.nih.gov/31003997/